Literature DB >> 9119977

Differential and time-dependent expression of monocyte chemoattractant protein-1 mRNA by astrocytes and macrophages in rat brain: effects of ischemia and peripheral lipopolysaccharide administration.

N G Gourmala1, M Buttini, S Limonta, A Sauter, H W Boddeke.   

Abstract

Increasing evidence indicates a key role of chemoattractant cytokines in the accumulation of leukocytes in the central nervous system (CNS) during the course of inflammatory processes. Monocyte chemoattractant protein (MCP-1/JE), a member of the beta-chemokine (C-C chemokine) family, functions as a potent chemoattractant and activator for monocytes. We have investigated the induction of MCP-1 mRNA using in situ hybridization histochemistry (ISH) and characterized its cellular source by combination of ISH and immunocytochemistry in ischemic rat brains as well as in brains of endotoxin-treated rats. Our results show that 6 h-2 d after middle cerebral artery occlusion (MCAO), MCP-1 mRNA is present in astrocytes surrounding the ischemic tissue (penumbra). At later time points (after 4 d), MCP-1 mRNA is found in macrophages and reactive microglia in the infarcted tissue. Peripheral administration of the bacterial lipopolysaccharide (LPS) induced MCP-1 mRNA throughout the brain in a time-dependent manner (1 h-1 d, peak of expression 6-8 h) and was found in astrocytes. In summary, we have found expression of MCP-1 in (a) astrocytes and to a lesser extent in macrophages/reactive microglia after MCA-occlusion and in (b) astrocytes after peripheral administration of LPS. These findings support that MCP-1 is involved in the CNS response to acute trauma or infection and thus may play a key role in inflammatory processes of the brain.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9119977     DOI: 10.1016/s0165-5728(96)00203-2

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  36 in total

Review 1.  Chemokines and glial cells: a complex network in the central nervous system.

Authors:  Elena Ambrosini; Francesca Aloisi
Journal:  Neurochem Res       Date:  2004-05       Impact factor: 3.996

2.  Expression of MCP-1 in the hippocampus of SHRSP with ischemia-related delayed neuronal death.

Authors:  Yasuko Sakurai-Yamashita; Kazuto Shigematsu; Kimihiro Yamashita; Masami Niwa
Journal:  Cell Mol Neurobiol       Date:  2006-06-07       Impact factor: 5.046

Review 3.  Involvement of pro- and anti-inflammatory cytokines and chemokines in the pathophysiology of traumatic brain injury.

Authors:  Jenna M Ziebell; Maria Cristina Morganti-Kossmann
Journal:  Neurotherapeutics       Date:  2010-01       Impact factor: 7.620

4.  CCR2 deficiency in monocytes impairs angiogenesis and functional recovery after ischemic stroke in mice.

Authors:  Jordi Pedragosa; Francesc Miró-Mur; Amaia Otxoa-de-Amezaga; Carles Justicia; Francisca Ruíz-Jaén; Peter Ponsaerts; Manolis Pasparakis; Anna M Planas
Journal:  J Cereb Blood Flow Metab       Date:  2020-03-09       Impact factor: 6.200

5.  Direct comparison of microglial dynamics and inflammatory profile in photothrombotic and arterial occlusion evoked stroke.

Authors:  Maria L Cotrina; Nanghong Lou; Jessica Tome-Garcia; James Goldman; Maiken Nedergaard
Journal:  Neuroscience       Date:  2016-12-18       Impact factor: 3.590

6.  Chemokines and their receptors in intracerebral hemorrhage.

Authors:  Yao Yao; Stella E Tsirka
Journal:  Transl Stroke Res       Date:  2012-04-03       Impact factor: 6.829

7.  Implications of immune system in stroke for novel therapeutic approaches.

Authors:  Aaron A Hall; Keith R Pennypacker
Journal:  Transl Stroke Res       Date:  2010-01-13       Impact factor: 6.829

Review 8.  Neuroimmune communication in hypertension and obesity: a new therapeutic angle?

Authors:  Annette D de Kloet; Eric G Krause; Peng D Shi; Jasenka Zubcevic; Mohan K Raizada; Colin Sumners
Journal:  Pharmacol Ther       Date:  2013-02-28       Impact factor: 12.310

Review 9.  Role of chemokines in CNS health and pathology: a focus on the CCL2/CCR2 and CXCL8/CXCR2 networks.

Authors:  Bridgette D Semple; Thomas Kossmann; Maria Cristina Morganti-Kossmann
Journal:  J Cereb Blood Flow Metab       Date:  2009-11-11       Impact factor: 6.200

10.  CD38 exacerbates focal cytokine production, postischemic inflammation and brain injury after focal cerebral ischemia.

Authors:  Chi-un Choe; Kerstin Lardong; Mathias Gelderblom; Peter Ludewig; Frank Leypoldt; Friedrich Koch-Nolte; Christian Gerloff; Tim Magnus
Journal:  PLoS One       Date:  2011-05-13       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.